Nizar Batada net worth
Quick answer
Nizar Batada's estimated net worth is $20.0M (range $14.0M – $30.0M) as of 2026. Nizar Batada is CEO at Eugit Therapeutics. Eugit Therapeutics valuation.
Nizar Batada is CEO at Eugit Therapeutics (YC S22). Independent Entrepreneurial Check model estimate from public YC data.
At a glance
- Company status: Active
- Region: United States of America
- Industries: Healthcare, Therapeutics
- Team size: 2
- Website: http://www.eugittx.com
Who is Nizar Batada?
Nizar Batada is a founder at Eugit Therapeutics, a company focused on developing innovative therapeutic solutions. He is a Y Combinator participant, having been part of the Summer 2022 batch.
Highlights:
- Y Combinator S22
- Eugit Therapeutics
- Biotechnology
About Eugit Therapeutics
Eugit Therapeutics targets the issue of non-specific drugs that cause toxicity and clinical trial failures, affecting millions with tissue-specific inflammatory diseases. TAGHOME delivers drugs with precision to diseased tissues using T cell receptors, enhancing safety and improving efficacy. Our initial focus is on the 3.1 million U.S. individuals with Inflammatory Bowel Disease, aiming to initiate clinical...
FAQ: Nizar Batada net worth and Eugit Therapeutics valuation
What is Nizar Batada's net worth?
Nizar Batada's estimated net worth is $20.0M (range $14.0M – $30.0M) as of 2026. Nizar Batada is CEO at Eugit Therapeutics. Entrepreneurial Check publishes an independent model-based estimate from public company and role data. Not verified net worth, and Entrepreneurial Check is not affiliated with Y Combinator or the profiled companies.
What is Eugit Therapeutics valuation?
Eugit Therapeutics's estimated valuation on Entrepreneurial Check is $20.0M. That valuation, or a disclosed round when one is public, is the source for the paper-wealth estimate. Independent model output — not a verified appraisal or official mark.
What is Nizar Batada's role?
Nizar Batada is CEO at Eugit Therapeutics, a Y Combinator-backed startup (batch S22).